T80.311
ABO incompatibility with delayed hemolytic transfusion reaction
Clinical Classification Guidelines
Inclusion Terms
- ABO incompatibility with hemolytic transfusion reaction 24 hours or more after transfusion
- Delayed hemolytic transfusion reaction (DHTR) due to ABO incompatibility
Medical Intelligence & Overview
ABO incompatibility with delayed hemolytic transfusion reaction (DHTR) is a medical condition that occurs when the immune system responds to a blood transfusion due to incompatibility of blood types. Specifically, this condition happens more than 24 hours after a transfusion, leading to destruction of the red blood cells and potential health complications. Recognizing the causes, symptoms, and diagnostic approaches is essential for proper management of this condition.
Causes & Symptoms
Clinical Causes: Receiving blood from a donor whose ABO blood group does not match the recipient's blood type. Previous exposure to incompatible blood transfusions, leading to the development of antibodies. Incomplete blood typing or crossmatching before transfusion. Transfusion of contaminated or improperly prepared blood products.
Key Symptoms: Fever and chills occurring days after transfusion. Unexplained anemia or a sudden drop in hemoglobin levels. Jaundice, characterized by yellowing of the skin and eyes. Dark urine, indicating the breakdown of red blood cells. Fatigue or weakness due to decreased oxygen delivery. Flank or back pain in severe cases. In some cases, no symptoms are evident, making awareness crucial.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of delayed hemolytic transfusion reaction involves a combination of clinical assessment and laboratory testing. Key diagnostic steps include:
Treatment Protocols: Management of ABO incompatibility with DHTR focuses on supportive care and preventing further hemolysis. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T80.311 a billable ICD-10 code?
Yes, T80.311 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.311?
Clinical documentation must specify the nature of ABO incompatibility with delayed hemolytic transfusion reaction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference